Daniel Lundell Selected Research

Uridine Diphosphate (UDP)

5/2005

The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Lundell Research Topics

Disease

3	Arthritis (Polyarthritis) 06/2015 - 01/2010
3	Inflammation (Inflammations) 06/2015 - 01/2010
3	Experimental Arthritis 02/2012 - 04/2007
1	Disease Progression 02/2012
1	Rheumatoid Arthritis 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012
1	Multiple Sclerosis 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Obesity 01/2010
1	Astrocytoma (Pilocytic Astrocytoma) 05/2005

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 06/2015 - 01/2010
1	p38 Mitogen-Activated Protein KinasesIBA 02/2012
1	SCH 546738IBA 01/2012
1	CXCR3 ReceptorsIBA 01/2012
1	CollagenIBA 01/2010
1	CholesterolIBA 01/2010
1	Chemokine ReceptorsIBA 01/2010
1	Rosiglitazone (Avandia)FDA Link 01/2010
1	LigandsIBA 04/2007
1	ChemokinesIBA 05/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2005
1	Uridine Diphosphate (UDP)IBA 05/2005
1	Interleukin-8 (Interleukin 8)IBA 05/2005

Therapy/Procedure

1	Therapeutics 01/2012
1	Heart Transplantation (Grafting, Heart) 01/2012